Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 4-acetamido-N-(tert-butyl)benzamide | 183619-38-7 | 99.8% | 234.29 | C13H18N2O2 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY10037610MG

Encompass_Preferred

CPI-1189 is a small-molecule TNF-α release inhibitor used in preclinical research to investigate inflammatory and neuroprotective mechanisms. It has been reported to inhibit p38 phosphorylation and reduce apoptosis in cellular models, making it useful for studies of neurodegeneration, HIV-related neuronal injury, and oxidative stress.

  • Orally active TNF-α release inhibitor suitable for cell-based assays.
  • Modulates p38 signaling to reduce inflammation-related apoptosis.
  • High chemical purity for reproducible experimental results.
  • Available in small-scale quantities for research applications.
  • Supplied with datasheet listing CAS, molecular weight, and structural identifiers.

Catalog No. 50-002-13778


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.